The EULAR 2021 Podcast
This EULAR 2021 correspondent's podcast revisits six congress state-of-the-art presentations on rheumatology topics, and research findings where the discipline overlapped with pediatrics, gastroenterology, and virology.
What the congress brought us on passive smoking, FMT, the COVID-19 vaccine, and beyond.
This EULAR 2021 correspondent's podcast revisits six congress state-of-the-art presentations on rheumatology topics, and research findings where the discipline overlapped with pediatrics, gastroenterology, and virology.
Today's podcast discusses six presentations that took place during this year's European League Against Rheumatism (EULAR) 2021 congress, which took place digitally thsi year 2-5 June. The presentations covered in this podcast include:
-
A large prospective E3N-EPIC cohort study demonstrated that exposure to passive smoking in childhood and/or adulthood is associated with an increased risk of rheumatoid arthritis (RA).
-
Faecal microbiota transplantation (FMT) as an add-on therapy to methotrexate was inferior in the treatment of active peripheral psoriatic arthritis (PsA) compared with sham in the proof-of-concept, randomised, placebo-controlled FLORA trial.
-
The main conclusion of a prospective, longitudinal real-world study among RA patients in the UK demonstrated that remote management provides a feasible alternative for routine outpatient follow-up.
-
The risk of severe COVID-19 outcomes in patients with rheumatoid arthritis (RA) is 4 times higher for rituximab users and 2 times higher for JAK inhibitor users compared with TNF inhibitor users.
-
Updates on COVID-19 vaccines in patients with rheumatic disease.
-
The KEEPsAKE 2 trial showed that risankizumab leads to significantly greater improvements in signs and symptoms than placebo in patients with active psoriatic arthritis (PsA) who have shown inadequate response or intolerance to 1 or 2 biologic therapies or at least one DMARD therapy.
You can also visit esanum's dedicated page to the EULAR 2021 digital congress here.